We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Leading MS/PML experts have recommended genetic testing to prevent fatal brain infection in MS patients (Photo courtesy of Pexels)

Simple, Inexpensive Genetic Test Can Identify MS Patients at Risk of Fatal Brain Infection

Leading multiple sclerosis (MS) experts are recommending genetic testing to identify MS patients with an increased likelihood of experiencing serious medication side effects, particularly a fatal brain infection called progressive multifocal leukoencephalopathy (PML). More...
20 Mar 2023
Image: New diagnostic tests could accurately detect and pre-empt risks of debilitating diseases (Photo courtesy of Amplified Sciences)

Unique Dye-Based Tests to Revolutionize Early-Detection Pancreatic Cancer Diagnostics

Pancreatic cancer is the third deadliest cancer, with 74 out of every 100 patients succumbing to it within a year of diagnosis as it is often detected too late to be treated effectively. Now, that could change with the development of new tests that use dyes to detect the possibility of malignancy in fluid extracted from pancreatic cysts. When appropriately evaluated, these cysts can provide a means of detecting pancreatic cancer at an earlier stage. More...
17 Mar 2023
Image: A breakthrough non-invasive process allows to access lymph through the collection of surgical drain fluid after tumor resection (Photo courtesy of Droplet Biosciences)

Novel Lymph Liquid Biopsy Could Transform Approach for Identifying Cancer Recurrence Risk

Although the crucial role of the lymphatic system in metastasis has been acknowledged for some time, obtaining patient lymph for analysis has been difficult. Scientists have now pioneered a platform to collect and analyze patient lymph using surgical drain fluid, which is routinely accessible. This lymphatic fluid is abundant in T-cells, proteins, and other biomarkers, making it a valuable resource for gaining early and highly sensitive insights into the body's immune response to cancer compared to blood samples. More...
17 Mar 2023
Image: BD Vaginal Panel on BD COR System tests for multiple common types of vaginitis using only one swab, one test (Photo courtesy of BD)

First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis Uses Only One Swab

Accurate diagnosis of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and Trichomonas vaginalis (TV) is vital in determining the proper treatment and reducing the possibilities of associated complications and the buildup of drug resistance. Now, a comprehensive diagnostic test directly detects the three most common infectious causes of vaginitis using a high-throughput molecular diagnostic platform for large laboratories. More...
17 Mar 2023
Image: The biosensor could help optimize cancer treatment, identify DNA damage factors, and elucidate repair mechanisms (Photo courtesy of Pexels)

Novel Biosensor to Detect DNA Damage in Real Time Could Revolutionize Cancer Treatment

Scientists have invented a new biosensor that utilizes fluorescence resonance energy transfer (FRET) to spot DNA double-strand breaks in real-time in living specimens. The biosensor has the potential to transform cancer treatment by providing doctors with an understanding of how cells respond to therapeutic treatments and also aid in the discovery of new DNA repair drugs. More...
16 Mar 2023
Image: Elevated hs-cTnI levels can precede and predict pre-eclampsia (Photo courtesy of Pexels)

High-Sensitivity Troponin I Could Predict Preeclampsia in High-Risk Women

A new study has found High Sensitivity Cardiac Troponin I (hs-cTnI) to be significantly higher in pregnant women who go on to develop preeclampsia starting at 14 weeks. More...
16 Mar 2023
Image: Proteins that glow bright blue or green could make disease diagnosis quicker and easier (Photo courtesy of Eindhoven University of Technology)

‘Glow-In-The-Dark’ Proteins to Help Diagnose Viral Diseases More Quickly and Easily

A team of researchers has come up with a sensitive technique that analyzes viral nucleic acids in as little as 20 minutes and can be finished in one step using “glow-in-the-dark” proteins. More...
16 Mar 2023
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Sample Transportation System
Tempus1800 Necto


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.